Larvol Delta - Debio-0123106-A-phase-1-trial-to-study-how-safe-and-tolerable-Lunresertib-is-alone-or-in-Combination-with-RP3500-or-Debio-0123-whennadministered-in-patients-with-certain-types-of-cancer

camonsertib (RP-3500) - XenoTherapeutics

lunresertib (Debio2513) - Debiopharm

zedoresertib (Debio 0123) - Debiopharm

https://euclinicaltrials.eu/ctis-public/view/2023-510063-35-00

Jun 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next